(Q51272232)

English

Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.

scientific article published in July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats. (English)

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

author name string

Xue Ma

1

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Jingru Meng

2

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Min Jia

3

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Long Bi

4

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Ying Zhou

5

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Yukun Wang

6

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Jing Hu

7

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Gonghao He

8

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Xiaoxing Luo

9

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

publication date

1 July 2013

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

28

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

7

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

1641-1652

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Update in osteoporosis and metabolic bone disorders

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Osteoporosis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Potential role of pancreatic and enteric hormones in regulating bone turnover.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Role of gastrointestinal hormones in postprandial reduction of bone resorption

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Incretin-based therapies: mimetics versus protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Management of type 2 diabetes: new and future developments in treatment

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Bone: incretin hormones perceiver or receiver?

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

The ovariectomized rat model of postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Biomechanics of bone: determinants of skeletal fragility and bone quality

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Long-term effects of ovariectomy and aging on the rat skeleton

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Is Calcitonin an Important Physiological Substance?

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Bone marrow fat is inversely related to cortical bone in young and old subjects

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Obesity and fractures in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Statins, hormones, and women: benefits and drawbacks for atherosclerosis and osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

New factors controlling the balance between osteoblastogenesis and adipogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Disassociation of bone resorption and formation by GLP-2

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Four-month treatment with GLP-2 significantly increases hip BMD

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1898

21 January 2018

Identifiers

10.1002/JBMR.1898

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23427056

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51272232&oldid=944815146"